Impact of Notifi Cations on Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in OldeR Adults (INNSPIOR)

Sponsor
Tokyo University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06135740
Collaborator
(none)
350
1
2
13.8
25.4

Study Details

Study Description

Brief Summary

The current study is nested within an established cohort based in Kashiwa City in Japan, which consists of older adults living independently in purpose built housing operated by Mitsui Fudosan, a large real estate company. The inclusion criteria of this study is age equal to or older than 65 years and functional independence (i.e., not requiring nursing care provided by long-term care insurance). We plan to conduct a randomized controlled trial within the Kashiwa cohort to test the effectiveness of notification based on Fitbit recorded data, used to prompt health and wellness actions on a variety of health outcomes, compared to usual care. Results of this trial will be valuable for informing further implementation of Fitbits and related wearables in elderly populations in Japan and other countries in the region.

Condition or Disease Intervention/Treatment Phase
  • Device: Notification for sleep, activity and nutrition based fitbit data
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
350 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
Impact of Notifi Cations on Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in OldeR Adults (INNSPIOR)
Actual Study Start Date :
Nov 8, 2023
Anticipated Primary Completion Date :
Jul 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention

Device: Notification for sleep, activity and nutrition based fitbit data
Those who meet the inclusion criteria for intervention will receive automatically generated notifications that include lifestyle recommendations.

Sham Comparator: Control

Device: Notification for sleep, activity and nutrition based fitbit data
Those who meet the inclusion criteria for intervention will receive automatically generated notifications that include lifestyle recommendations.

Outcome Measures

Primary Outcome Measures

  1. Intellectual property and muscle mass [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 92 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Over 65 years of age.

  • Living in Japan.

  • Living independently with or without carer support.

  • Able and willing to wear a Fitbit for the duration of the study (≥20 hours a day, including during sleep).

  • Individuals that are able and willing to receive and act on interventions.

  • Has capacity to consent to inclusion in the study.

  • Smartphone access to allow Fitbit installation and setup.

  • Has one or more of the following comorbidities:

  • BMI <20 (65-69 years), <21.5 (≥70 years)

  • Pre-frail or Frail: scoring 1-2 (pre-frail) or 3+ (frail) based on the FRAIL questionnaire (citation)

  • Sarcopenia: low grip strength (female <18 kg, male <28 kg); Gait speed (< 1m/s); low Skeletal Muscle mass Index (female 5.7 kg/m2; male 7 kg/m2)

Exclusion Criteria:
  • Individuals receiving full time care in a care facility.

  • Individuals that are unable to receive and/or act on interventions.

  • Individuals who are existing wearable users, or who have prior experience using a wearable to manage their health.

  • Individuals with uncontrolled hypertension, diabetes, CKD or with cardiac pacemakers and/or cardiovascular stent(s).

  • Individuals who have any additional condition or situation that the Investigator (PI) or designee determines as inappropriate for participation in this study.

  • Individuals with no comorbidities as defined above.

Contacts and Locations

Locations

Site City State Country Postal Code
1 TUniversity Kashiwa Chiba Japan 2778562

Sponsors and Collaborators

  • Tokyo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tatsuhiro Hisatsune, Associate Professor, Tokyo University
ClinicalTrials.gov Identifier:
NCT06135740
Other Study ID Numbers:
  • 22-360
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023